ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Fredun Pharmaceuticals Ltd reported revenue from operations of ₹227.8 Cr (+90.8% YoY) and net profit of ₹13.1 Cr (+92.6% YoY) for Q1 FY27.
Fredun Pharmaceuticals reported audited FY26 financial results and recommended a 7% final dividend. The board also approved a 2:1 bonus share issue and increased authorized capital.
Fredun Pharmaceuticals Ltd reported revenue from operations of ₹210.4 Cr (+27.2% YoY) and net profit of ₹10.8 Cr (+80.0% YoY) for Q4 FY26.
Fredun Pharmaceuticals approved FY2026 audited financial results and recommended a 7% final dividend. The board also proposed a 2:1 bonus share issue and increased authorized capital.